PNC Financial Services Group’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12
| Closed | -$15 | – | 5012 |
|
|
2025
Q1 | $15 | Buy |
+12
| New | +$31 | ﹤0.01% | 4870 |
|
|
2024
Q3 | – | Sell |
-39
| Closed | -$166 | – | 4864 |
|
|
2024
Q2 | $166 | Hold |
39
| – | – | ﹤0.01% | 4686 |
|
|
2024
Q1 | $574 | Buy |
39
+34
| +680% | +$514 | ﹤0.01% | 4477 |
|
|
2023
Q4 | $48 | Buy |
+5
| New | +$35 | ﹤0.01% | 4569 |
|
|
2022
Q1 | – | Sell |
-16
| Closed | – | – | 4636 |
|
|
2021
Q4 | $0 | Sell |
16
-599
| -97% | -$11.3K | ﹤0.01% | 4550 |
|
|
2021
Q3 | $13K | Hold |
615
| – | – | ﹤0.01% | 3671 |
|
|
2021
Q2 | $17K | Hold |
615
| – | – | ﹤0.01% | 3537 |
|
|
2021
Q1 | $20K | Hold |
615
| – | – | ﹤0.01% | 3410 |
|
|
2020
Q4 | $14K | Buy |
615
+599
| +3,744% | +$13.8K | ﹤0.01% | 3469 |
|
|
2020
Q3 | $0 | Sell |
16
-3
| -16% | -$82 | ﹤0.01% | 3991 |
|
|
2020
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 3854 |
|
|
2020
Q1 | $0 | Sell |
19
-223
| -92% | -$2.02K | ﹤0.01% | 3993 |
|
|
2019
Q4 | $3K | Buy |
242
+223
| +1,174% | +$2.21K | ﹤0.01% | 3734 |
|
|
2019
Q3 | $0 | Sell |
19
-9
| -32% | -$130 | ﹤0.01% | 4068 |
|
|
2019
Q2 | $0 | Sell |
28
-85
| -75% | -$1.46K | ﹤0.01% | 4089 |
|
|
2019
Q1 | $2K | Buy |
113
+86
| +319% | +$1.49K | ﹤0.01% | 3882 |
|
|
2018
Q4 | $0 | Hold |
27
| – | – | ﹤0.01% | 4126 |
|
|
2018
Q3 | $1K | Hold |
27
| – | – | ﹤0.01% | 4046 |
|
|
2018
Q2 | $1K | Buy |
27
+19
| +238% | +$428 | ﹤0.01% | 4064 |
|
|
2018
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 4239 |
|
|
2017
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 4202 |
|
|
2017
Q3 | $0 | Sell |
8
-74,670
| -100% | -$1.29M | ﹤0.01% | 4192 |
|
|
2017
Q2 | $1.31M | Sell |
74,678
-573
| -0.8% | -$10.9K | ﹤0.01% | 1154 |
|
|
2017
Q1 | $1.4M | Buy |
75,251
+75,061
| +39,506% | +$1.45M | ﹤0.01% | 1155 |
|
|
2016
Q4 | $4K | Sell |
190
-53,408
| -100% | -$1.34M | ﹤0.01% | 3726 |
|
|
2016
Q3 | $1.6M | Buy |
53,598
+53,459
| +38,460% | +$1.59M | ﹤0.01% | 1076 |
|
|
2016
Q2 | $4K | Sell |
139
-6
| -4% | -$135 | ﹤0.01% | 3930 |
|
|
2016
Q1 | $3K | Buy |
145
+5
| +4% | +$95 | ﹤0.01% | 4052 |
|
|
2015
Q4 | $4K | Hold |
140
| – | – | ﹤0.01% | 3949 |
|
|
2015
Q3 | $3K | Buy |
140
+5
| +4% | +$157 | ﹤0.01% | 4157 |
|
|
2015
Q2 | $5K | Buy |
135
+61
| +82% | +$2K | ﹤0.01% | 4073 |
|
|
2015
Q1 | $2K | Buy |
+74
| New | +$2.51K | ﹤0.01% | 4309 |
|
Other funds holding MGNX
BG
AC
WA
FLSM
EC
PNC Financial Services Group's MGNX Position: Q2 2025 in Review
PNC Financial Services Group sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 12 shares — an estimated $15 sold.
PNC Financial Services Group first reported a position in MGNX in Q1 2015 and held it in 32 quarters. The position peaked at $1.6M in Q3 2016. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.
- PNC Financial Services Group reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
- PNC Financial Services Group sold 12 MacroGenics shares in Q2 2025, an estimated $15.
- PNC Financial Services Group first reported a position in MacroGenics in Q1 2015 and held it in 32 quarters.
- PNC Financial Services Group's MacroGenics position peaked at $1.6M in Q3 2016.
- 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.
Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.